Kommentar

• Literatur

• 1 Déchelotte P, Hasselmann M, Cynober L et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in criticall ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006; 34: 598-604
• 2 Bakalar B, Duska F, Pachl J et al. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple trauma patients. Crit Care Med 2006; 34: 381-386